Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa
Latest Information Update: 24 May 2016
At a glance
- Drugs Unoprostone (Primary)
- Indications Retinitis pigmentosa
- Focus Adverse reactions; Therapeutic Use
- Sponsors R-Tech Ueno Ltd
- 24 May 2016 New trial record